borderline significantP = 0.065
In terms of maternal outcomes, the overall incidence of adverse outcomes was higher in patients with gene mutations, and this difference was borderline significant (20.0% vs 9.2%, P = 0.065).
In terms of maternal outcomes, the overall incidence of adverse outcomes was higher in patients with gene mutations, and this difference was borderline significant (20.0% vs 9.2%, P = 0.065).